CEO, Johnson & Johnson
In September, Johnson & Johnson said it was starting large-scale Phase 3 trials of its potential coronavirus vaccine. J&J wasn’t the first to reach that benchmark, but it did have an advantage over rivals: Its potential treatment, made with the same technology as its experimental Ebola vaccine, requires only one dose.
As leader of the world’s largest drug company, Gorsky is also taking responsibility for making sure the public can trust that a coronavirus treatment has been approved without political interference. Amid growing fears that the Trump administration would rush a vaccine to the public, Gorsky was one of the handful of pharmaceutical executives who pledged that their companies would use only the highest ethical and scientific standards to verify the efficacy of a potential vaccine.